Product Information
BLISOVI FE 1-20 TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1311 per EA under NDC 68180086573. Its NADAC has been published 337 times since Jan 15, 2020.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180086573
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA201584On Market Since
4/1/2019
Price Statistics
The NADAC for BLISOVI FE 1-20 TABLET has been published 337 times since Jan 15, 2020, and over the history we have for it it has declined 60.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1311 per EA |
|---|---|
| All-time high | $0.3795 (Feb 12, 2020) |
| All-time low | $0.1176 (May 22, 2024) |
| 52-week high | $0.1517 |
| 52-week low | $0.1277 |
| Median price | $0.1625 |
| Average price | $0.1956 |
| Largest weekly change | +35.6% (Jun 17, 2020) |
| Weeks tracked | 337 |
| Tracking since | Jan 15, 2020 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BLISOVI FE 1-20 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BLISOVI FE 1-20 TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1311 per EA (NDC 68180086573), effective Jun 24, 2026.
How has the price of BLISOVI FE 1-20 TABLET changed over time?
Over the history we have for it, the NADAC for BLISOVI FE 1-20 TABLET has declined 60.2%. It has been tracked across 337 weekly CMS publications since Jan 15, 2020.
What are the highest and lowest recorded NADAC prices for BLISOVI FE 1-20 TABLET?
Since Jan 15, 2020, the NADAC for BLISOVI FE 1-20 TABLET has ranged from a low of $0.1176 (May 22, 2024) to a high of $0.3795 (Feb 12, 2020), with a median of $0.1625 per EA.
Are there cheaper alternatives to BLISOVI FE 1-20 TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as BLISOVI FE 1-20 TABLET, but none are currently priced below it.
Who manufactures BLISOVI FE 1-20 TABLET?
BLISOVI FE 1-20 TABLET (NDC 68180086573) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification